What is Dianthus Therapeutics's capex?

Dianthus Therapeutics (DNTH) reported capex of $10K in Q1 2026.

How has Dianthus Therapeutics's capex changed year-over-year?

Dianthus Therapeutics's capex decreased by 58.3% year-over-year, from $24K to $10K.

What is the long-term trend for Dianthus Therapeutics's capex?

Over 2 years (2021 to 2024), Dianthus Therapeutics's capex has grown at a -71.2% compound annual growth rate (CAGR), from $1.26M to $105K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Dianthus Therapeutics DNTH CapEx

CapEx at other companies

Johnson & JohnsonJNJ

$1.05B+31.9%

AmgenAMGN

$712M+73.2%

Kymera TherapeuticsKYMR

$434K-7.1%

Protagonist TherapeuticsPTGX

$215K-60.6%

TG TherapeuticsTGTX

$51K+104%

Immunovant, Inc.IMVT

$8K-96.0%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Enterprise value$3.88B+565%

P/S1,465.1×+962×

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForCapitalImprovements.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's capex?: Dianthus Therapeutics (DNTH) reported capex of $10K in Q1 2026.
How has Dianthus Therapeutics's capex changed year-over-year?: Dianthus Therapeutics's capex decreased by 58.3% year-over-year, from $24K to $10K.
What is the long-term trend for Dianthus Therapeutics's capex?: Over 2 years (2021 to 2024), Dianthus Therapeutics's capex has grown at a -71.2% compound annual growth rate (CAGR), from $1.26M to $105K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.